The future of medicine is here.

We owe every life-changing drug on the market to clinical trials.

About Us 2021

So why has the pharmaceutical industry fallen short when it comes to the needs of the very people who drive its progress and breakthroughs?

Patient-centric trials recruit participants almost twice as fast and launch their drugs 19% more often. But in reality, patient-centric designs are only used in 5% of Phase II and III trials. Only 500 of 7,000 known diseases currently have a treatment. And not only does it take an average of 10 years for a new drug to go through clinical trials, only 5% of studied drugs make it to drugstore shelves. The result: millions of people left waiting longer for a better treatment for their illnesses.

The world of clinical trials needs a shake-up. So let’s do something about it. At TrialSpark, patient-centric is not just a buzzword or an afterthought. It’s the backbone to everything we do. And it’s a promise. We put the patient in the driver’s seat before, during, and after a trial. Because it’s not just doctors who help build a healthier future. It’s patients. And it’s time to do right by them.

About Us - Hero - Illustration

About Us Image 2021

Our Investors

Meet the people investing in a brighter future for medicine with us.

Investor Logo - Sequoia
Investor Logo - Thrive Capital

Stay up to date on new trials.

We’ll keep you updated on emerging treatments.

By submitting, you are agreeing to our Privacy Policy.